⌘K
Loading ticker…
As of 2026-08-25, GeoVax Labs, Inc. New (GOVX) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 23. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.6%, relative volume 0.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
GOVX is in a stage 4 downtrend, week 11. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -32.3% / -78.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
GOVX appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $4K notional.
Held by 1 ETFs · $4K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $4K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GOVX Jan avg: -16.83% median: -28.59% win: 25% σ: 30.87% n: 4 2022-04-12 → 2026-07-31 | GOVX Feb avg: -26.87% median: -23.86% win: 0% σ: 11.17% n: 4 2022-04-12 → 2026-07-31 | GOVX Mar avg: -15.78% median: -17.81% win: 0% σ: 11.09% n: 4 2022-04-12 → 2026-07-31 | GOVX Apr avg: -17.78% median: -21.01% win: 0% σ: 11.36% n: 5 2022-04-12 → 2026-07-31 | GOVX May avg: 48.61% median: 29.99% win: 100% σ: 54.96% n: 5 2022-04-12 → 2026-07-31 | GOVX Jun avg: -8.52% median: -15.13% win: 20% σ: 49.70% n: 5 2022-04-12 → 2026-07-31 | GOVX Jul avg: 26.97% median: -16.80% win: 40% σ: 114.45% n: 5 2022-04-12 → 2026-07-31 | GOVX Aug avg: 17.66% median: 2.24% win: 75% σ: 75.23% n: 4 2022-04-12 → 2026-07-31 (current) | GOVX Sep avg: -25.94% median: -23.70% win: 0% σ: 19.42% n: 4 2022-04-12 → 2026-07-31 | GOVX Oct avg: -4.04% median: -8.73% win: 25% σ: 16.88% n: 4 2022-04-12 → 2026-07-31 | GOVX Nov avg: -5.58% median: -14.49% win: 25% σ: 27.09% n: 4 2022-04-12 → 2026-07-31 | GOVX Dec avg: -25.30% median: -18.18% win: 0% σ: 22.84% n: 4 2022-04-12 → 2026-07-31 |